
Ivig (Intravenous Immunoglobulin) Solution Suppliers & Bulk Manufacturers
Available Forms: Intravenous infusion
Available Strengths: 5% or 10%
Reference Brands: Gammagard (Gamunex-C, Flebogamma),Privigen, Octagam, Gamunex-C(US)
Category: Immune Disorder
IVIG (Intravenous Immunoglobulin) solution is available in Intravenous infusion and strengths such as 5% or 10%. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, IVIG (Intravenous Immunoglobulin) solution is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Technical Specifications & Supply Details | |
---|---|
Lead Time | 7 to 60 days (depending on batch size & schedule) |
MOQ | As per manufacturer’s batch size |
COA | Available with every batch |
Regulatory Dossier / DMF | Available upon request |
Export Documentation | FSC, COA, Manufacturing License, Product Permission |
Standards | IP, BP, USP |
Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
IVIG (Intravenous Immunoglobulin) solution can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: IVIG (Intravenous Immunoglobulin) solution, marketed as Gammagard or Privigen, is approved in the US by the FDA and in the EU via EMA for passive immunity against specific infections, such as varicella-zoster and other viral diseases. Regulatory approval requires a detailed dossier including clinical efficacy, safety, manufacturing quality, and pharmacovigilance plans. In the US, the FDA rigorously reviews clinical trial and production data, while the EMA ensures compliance with regional safety and quality standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper compliance is essential for timely approval and safe use of VIG products worldwide, supporting effective infection prevention.
Frequently Asked Questions
Related Products
Belimumab Prefilled Syringe
Strength: 200 mg/ten 1 mL for SQ; 10 mg/mL for IV
Form: Subcutaneous (SC) and intravenous (IV) Prefilled syringe
Reference Brands: Benlysta(US & EU)
View DetailsAnakinra Injection
Strength: 100 mg/mL
Form: Injection(SQ)
Reference Brands: Kinerso, Kineret(US)
View DetailsUstekinumab Injection
Strength: SQ:: 45 mg, 90 mg; IV: 130 mg/vial
Form: SQ and IV injection
Reference Brands: Stelara(US)
View DetailsEverolimus Tablets
Strength: 0.75 mg, 1.25 mg, 2.5 mg, 5 mg, 7.5 mg, 10 mg
Form: Tablet
Reference Brands: Zortress, Afinitor(US & EU)
View DetailsQuick Response Guaranteed | Verified Suppliers